Task: Answer the multiple-choice question.
Query: Which drug exhibits a 6.775% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] O=C(O)c1ccc(-c2noc(-c3cccc(C(F)(F)F)c3)n2)cc1
[b] COc1cc(C(=S)N2CCCC2)cc(Cl)c1O
[c] COc1ccc(CNC(=O)CCCOc2cc(=O)n(C)c3ccccc23)cc1
Answer: b. COc1cc(C(=S)N2CCCC2)cc(Cl)c1O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc(C(=S)N2CCCC2)cc(Cl)c1O
COc1cc(C(=S)N2CCCC2)cc(Cl)c1O
(3-chloro-4-hydroxy-5-methoxyphenyl)-pyrrolidin-1-ylmethanethione